PRME240719C2500
- 2.75
- 0.000.00%
Prime Medicine Newsroom
Prime Medicine (PRME) Gains 16.4% in 3 Months: Buy Now or Wait?
Lexeo Stock Drops 24% Amid Friedreich Ataxia Study Results
Prime Medicine, Inc. (PRME): Why Do Analysts Love This Shorted Stock Right Now?
Wall Street Analysts Believe Prime Medicine, Inc. (PRME) Could Rally 120.95%: Here's Is How to Trade
Prime Medicine to Present at Upcoming Investor Conferences
GFS, PETS and CYTK Are Among After Hour Movers
URBN, SHLS and VSAT Are Among After Hour Movers
Cathie Wood Pulls the Trigger on These 2 'Strong Buy' Stocks
Prime Medicine Initiated at Buy by HC Wainwright & Co.
Express News | Prime Medicine, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $10
Alphabet Bought Shares of 2 Underperfomers -- Barron's
Express News | Citigroup Upgrades Prime Medicine to Buy, Announces $10 Price Target
Express News | Prime Medicine Inc : Citigroup Raises to Buy From Neutral
Express News | Shares of 'Meme Stocks' and High-short Interest Stocks Are Trading Higher Amid a Renewed Surge in the Space After Popular Retail Trader 'Roaring Kitty' Returned to Social Media
Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans?
Express News | Prime Medicine Inc : Guggenheim Cuts Target Price to $18 From $20
Onward and Upward: Prime Medicine's (PRME) Extended-Session Rally
Stocks With More Than 10% Short Interest - Finviz Screener
Prime Medicine Price Target Cut to $15.00/Share From $16.00 by JP Morgan
Prime Medicine Is Maintained at Overweight by JP Morgan